The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered ...

Despite showing a progression-free survival benefit, the antibody-drug conjugate did not improve overall survival in HR-positive, HER2-negative or -low breast cancer.

AstraZeneca has a new at-home flu vaccine coming out. When will it arrive and how will it be administered? Here's what to ...

"For more than two decades Aaron has earned the trust of life science leaders for his deep expertise in the industry and delivering for his clients," said Curtis Lane, Founding Partner of MTS. "We are ...

UK shares ended higher on Monday, driven by gains in commodity-linked shares, particularly precious metal miners, amidst rising gold prices. Heavyweight energy shares also tracked elevated crude oil ...

FluMist, a nasal spray vaccine, can be self-administered and is approved for two-year-olds up to 49-year-olds. It has to be prescribed before purchase.

By Lisa Pauline Mattackal and Shashwat Chauhan (Reuters) -UK shares ended higher on Monday after logging their worst day ...

Black Diamond Therapeutics and Ideaya Biosciences are mulling over registrational trials for their lead assets after ...

AstraZeneca PLC AZN shares dropped 1.66% to £115.84 Monday, on what proved to be an all-around great trading session for the ...

I love being able to go to the pharmacy for my own (or my kids’) flu shots. Pop in, get the shot, then go about my day. That ...

Black Diamond Therapeutics reports promising initial Phase 2 data for BDTX-1535 in relapsed EGFR-mutant NSCLC patients. With ...

AstraZeneca said on Monday its experimental precision drug developed with Japan's Daiichi Sankyo did not significantly ...